LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $316,000 | -25.1% | 98,941 | 0.0% | 0.00% | – |
| Q1 2022 | $422,000 | -4.5% | 98,941 | +4.2% | 0.00% | – |
| Q4 2021 | $442,000 | +18.5% | 94,979 | +1.6% | 0.00% | – |
| Q3 2021 | $373,000 | -6.8% | 93,479 | 0.0% | 0.00% | – |
| Q2 2021 | $400,000 | -76.1% | 93,479 | -76.4% | 0.00% | – |
| Q1 2021 | $1,677,000 | -2.2% | 395,520 | -10.4% | 0.00% | – |
| Q4 2020 | $1,714,000 | +4.3% | 441,651 | +8.2% | 0.00% | – |
| Q3 2020 | $1,644,000 | -4.9% | 408,031 | +0.6% | 0.00% | – |
| Q2 2020 | $1,728,000 | +0.5% | 405,606 | -0.9% | 0.00% | – |
| Q1 2020 | $1,720,000 | +2.0% | 409,448 | -4.6% | 0.00% | – |
| Q4 2019 | $1,686,000 | -55.2% | 429,058 | +0.4% | 0.00% | – |
| Q3 2019 | $3,762,000 | -2.2% | 427,553 | +2.9% | 0.00% | – |
| Q2 2019 | $3,845,000 | +40.7% | 415,663 | -2.2% | 0.00% | – |
| Q1 2019 | $2,733,000 | -28.9% | 425,017 | +4.3% | 0.00% | – |
| Q4 2018 | $3,842,000 | -88.4% | 407,397 | -75.3% | 0.00% | -100.0% |
| Q3 2018 | $33,153,000 | -25.3% | 1,647,117 | +8.3% | 0.00% | -25.0% |
| Q2 2018 | $44,367,000 | +0.6% | 1,520,888 | +2.7% | 0.00% | 0.0% |
| Q1 2018 | $44,086,000 | +60.0% | 1,480,288 | +72.9% | 0.00% | +100.0% |
| Q4 2017 | $27,551,000 | +6.1% | 856,186 | +14.7% | 0.00% | 0.0% |
| Q3 2017 | $25,963,000 | -26.1% | 746,492 | -36.8% | 0.00% | -33.3% |
| Q2 2017 | $35,140,000 | +234.1% | 1,180,368 | +235.1% | 0.00% | +200.0% |
| Q1 2017 | $10,519,000 | +163.5% | 352,287 | +54.8% | 0.00% | – |
| Q4 2016 | $3,992,000 | -21.6% | 227,561 | +6.3% | 0.00% | -100.0% |
| Q3 2016 | $5,094,000 | +50.4% | 214,066 | +1.1% | 0.00% | – |
| Q2 2016 | $3,387,000 | -24.8% | 211,786 | -1.7% | 0.00% | – |
| Q1 2016 | $4,503,000 | -63.6% | 215,413 | -53.0% | 0.00% | -100.0% |
| Q4 2015 | $12,374,000 | +163.3% | 458,374 | +171.0% | 0.00% | 0.0% |
| Q3 2015 | $4,699,000 | +102.3% | 169,152 | +78.6% | 0.00% | – |
| Q2 2015 | $2,323,000 | – | 94,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |